{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "Tesamorelin Research",
  "home_page_url": "https://tesamorelin-research.com/",
  "feed_url": "https://tesamorelin-research.com/feed.json",
  "description": "Tesamorelin research — FDA-approved GHRH analog studied for growth hormone secretion, visceral adipose tissue reduction, HIV lipodystrophy, cognitive function, and metabolic optimization.",
  "language": "en-US",
  "authors": [
    {
      "name": "Tesamorelin Research",
      "url": "https://tesamorelin-research.com"
    }
  ],
  "hubs": [
    {
      "type": "WebSub",
      "url": "https://pubsubhubbub.appspot.com/"
    }
  ],
  "items": [
    {
      "id": "https://tesamorelin-research.com/articles/what-is-tesamorelin-ghrh-analog-research/",
      "url": "https://tesamorelin-research.com/articles/what-is-tesamorelin-ghrh-analog-research/",
      "title": "What Is Tesamorelin? GHRH Analog Research Review",
      "summary": "Research review of Tesamorelin — the synthetic GHRH analog studied for growth hormone secretion and visceral adipose tissue reduction.",
      "date_published": "2026-01-15T00:00:00Z",
      "date_modified": "2026-04-09T00:00:00Z",
      "authors": [{ "name": "Tesamorelin Research" }],
      "tags": ["Peptide Deep Dive"]
    },
    {
      "id": "https://tesamorelin-research.com/articles/growth-hormone-releasing-pathways-ghrh-vs-ghs-r/",
      "url": "https://tesamorelin-research.com/articles/growth-hormone-releasing-pathways-ghrh-vs-ghs-r/",
      "title": "Growth Hormone Releasing Pathways: GHRH vs GHS-R Mechanisms",
      "summary": "Two pathways, one outcome: how GHRH receptor and ghrelin receptor (GHS-R) signaling converge on growth hormone release, and why combining them matters.",
      "date_published": "2026-01-15T00:00:00Z",
      "date_modified": "2026-04-09T00:00:00Z",
      "authors": [{ "name": "Tesamorelin Research" }],
      "tags": ["Research Science"]
    },
    {
      "id": "https://tesamorelin-research.com/articles/growth-hormone-secretagogues-complete-research-guide/",
      "url": "https://tesamorelin-research.com/articles/growth-hormone-secretagogues-complete-research-guide/",
      "title": "Growth Hormone Secretagogues: A Complete Research Guide",
      "summary": "Everything researchers need to know about GH secretagogues — Ipamorelin, CJC-1295, GHRP-6, Tesamorelin, and how they differ in mechanism and selectivity.",
      "date_published": "2026-01-15T00:00:00Z",
      "date_modified": "2026-04-09T00:00:00Z",
      "authors": [{ "name": "Tesamorelin Research" }],
      "tags": ["Category Roundup"]
    },
    {
      "id": "https://tesamorelin-research.com/articles/future-of-metabolic-peptide-research/",
      "url": "https://tesamorelin-research.com/articles/future-of-metabolic-peptide-research/",
      "title": "The Future of Metabolic Peptide Research",
      "summary": "Where metabolic peptide research is heading — oral formulations, multi-receptor agonists, mitochondrial targets, and the convergence of obesity and aging science.",
      "date_published": "2026-01-15T00:00:00Z",
      "date_modified": "2026-04-09T00:00:00Z",
      "authors": [{ "name": "Tesamorelin Research" }],
      "tags": ["Trending Research"]
    },
    {
      "id": "https://tesamorelin-research.com/articles/ipamorelin-selective-growth-hormone-secretagogue/",
      "url": "https://tesamorelin-research.com/articles/ipamorelin-selective-growth-hormone-secretagogue/",
      "title": "Ipamorelin: The Selective Growth Hormone Secretagogue",
      "summary": "Research review of Ipamorelin — the highly selective GHS-R agonist studied for growth hormone release without significant effects on cortisol, prolactin, or appetite.",
      "date_published": "2026-01-15T00:00:00Z",
      "date_modified": "2026-04-09T00:00:00Z",
      "authors": [{ "name": "Tesamorelin Research" }],
      "tags": ["Peptide Deep Dive"]
    }
  ]
}